CME
CME GROUP INC.
NASDAQ · Financial Services · Financial - Data & Stock Exchanges · US
$305.12
+0.35%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.0B | 6.5B | 6.1B | 5.6B | 5.0B |
| Cost of Revenue | 1.1B | 907.0M | 850.3M | 828.6M | 753.1M |
| Gross Profit | 5.9B | 5.6B | 5.3B | 4.8B | 4.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 451.5M | 150.5M | 132.7M | 144.4M | 137.4M |
| General & Admin Expense | 451.5M | 150.5M | 132.7M | 144.4M | 137.4M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 850.0M | 1.2B | 1.2B | 1.2B | 1.1B |
| Total Operating Expenses | 1.3B | 1.4B | 1.3B | 1.3B | 1.3B |
| Cost and Expenses | 2.4B | 2.3B | 2.2B | 2.1B | 2.0B |
| Operating Income (EBIT) | 4.6B | 4.2B | 3.9B | 3.4B | 3.0B |
| Non-Operating | |||||
| Interest Income | 3.2B | — | — | — | — |
| Interest Expense | 87.2M | 129.7M | 160.9M | 159.4M | 162.7M |
| Net Interest Income | 3.1B | (129.7M) | (160.9M) | (159.4M) | (162.7M) |
| Other Non-Op Income/Expense | 1.2B | 1.1B | 609.9M | 717.9M | 474.4M |
| Non-Operating Income (excl Interest) | (1.7B) | (1.2B) | (770.8M) | (877.3M) | (637.1M) |
| EBT (Pre-Tax Income) | 5.8B | 5.3B | 4.5B | 4.2B | 3.5B |
| Income Tax Expense | 1.4B | 1.3B | 1.0B | 927.4M | 799.3M |
| Bottom Line | |||||
| Net Income | 4.4B | 4.0B | 3.5B | 3.2B | 2.7B |
| Earnings from Cont. Ops | 4.4B | 4.1B | 3.5B | 3.2B | 2.7B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 4.4B | 4.0B | 3.5B | 3.2B | 2.7B |
| Per Share | |||||
| Basic EPS | $12.26 | $11.18 | $9.69 | $8.87 | $7.41 |
| Diluted EPS | $12.19 | $11.16 | $9.67 | $8.86 | $7.40 |
| Revenue Per Share | $19.47 | $18.13 | $17.06 | $15.54 | $13.99 |
| Shares | |||||
| Basic Shares Outstanding | 358.0M | 359.6M | 359.4M | 359.0M | 358.7M |
| Diluted Shares Outstanding | 358.6M | 360.2M | 359.9M | 359.5M | 359.2M |
| Profitability Metrics | |||||
| EBITDA | 6.6B | 5.8B | 5.0B | 4.7B | 4.0B |
| D&A | 333.3M | 330.9M | 336.8M | 352.6M | 362.6M |
| EBIT | 6.3B | 5.4B | 4.7B | 4.3B | 3.7B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026